Marushika Technology IPO allotment date in focus: GMP jumps! Check steps to track status

Marushika Technology IPO allotment: Following the closure of Marushika Technology’s initial public offering (IPO), investor focus has now shifted to its allotment status.

Marushika Technology IPO allotment date is today, February 17. The Rs 27-crore IPO, which was open from February 12 to February 16, was booked 17.94 times. The qualified institutional buyer (QIB) quota was booked the least at 2.92 times. While participation from non-institutional and retail investors remained robust as their quotas were booked 41 times and 16.51 times, respectively according to Chittorgarh data.

Marushika Technology IPO price band was fixed at 111 Rs 117 per share. Investors could apply for the offer in lots of 1200 shares.

The offer was entirely a fresh share sale of 0.23 crore shares, with no offer-for-sale (OFS) component. This means that all proceeds will be received by the company, which it plans to use for repayment of debt, funding working capital needs and general corporate purposes.

Marushika Technology IPO Allotment Status

To check the Marushika Technology IPO allotment status, investors need to visit either the website of the registrar (Skyline Financial Services in this case) or the exchange NSE SME.

Steps to check Marushika Technology IPO allotment on NSE

Steps to check Marushika Technology IPO allotment on Skyline Financial

Marushika Technology IPO GMP

The gray market premium (GMP) for Marushika Technology IPO has jumped in the last two days, according to Investorgain.com. Marushika Technology IPO GMP today is 2. This means that shares of the company are trading 2 above the offer price of 117.

At the current GMP, Marushika Technology IPO listing price could be 119, signaling 1.71%

The shares of Marushika Technology are slated to list on the NSE SME on February 19.

NEXGEN Financial Solutions is the book-running lead manager, and Skyline Financial Services is the registrar of the issue.

Disclaimer: This story is for educational purposes only. We advise investors to consult with certified experts before making any investment decisions.

Source

Leave a Reply

Your email address will not be published. Required fields are marked *